Position in EYPT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,246,166
-$380,686 QoQ
Shares Held
96,677
+8.6% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 18.61766500822326.ToString("F0")%
Shared 0.ToString("F0")%
None 81.38233499177674.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. EYPT ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in EYPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,246,166 | 96,677 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,626,852 | 89,045 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,287,196 | 90,393 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $905,994 | 96,280 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $470,087 | 86,732 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $667,222 | 89,560 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $616,164 | 77,117 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $668,447 | 76,833 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,197,537 | 57,936 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,066,295 | 46,140 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $333,598 | 41,752 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $351,688 | 40,424 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $115,295 | 39,216 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $132,072 | 37,735 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $296,387 | 37,470 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $278,023 | 35,327 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $357,975 | 29,463 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $269,586 | 22,025 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $229,385 | 22,014 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $185,634 | 20,649 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||